Grifols (GIKLY) EBT (2010 - 2020)
Grifols (GIKLY) reported EBT of $277.4 million for Q1 2020, up 70.84% on a YoY basis from $162.4 million in Q2 2019, and down 55.09% quarter-over-quarter from $617.6 million in Q4 2019.
Grifols (GIKLY) EBT (2010 - 2020) Analysis & Trends
Grifols has reported EBT for 10 years, with the latest figure at $277.4 million in Q1 2020.
- For the quarter ending Q1 2020, EBT rose 70.84% year-over-year to $277.4 million; the trailing twelve-month figure through Mar 2020 stood at $1.7 billion (up 26.65% YoY), and the FY2025 full-year result was $715.9 million, up 50.89% from the prior year.
- EBT for Q1 2020 stood at $277.4 million, down from $617.6 million in the prior quarter.
- The five-year high for EBT was $694.7 million in Q4 2017, with the low at $162.4 million in Q1 2019.
- Historically, EBT has averaged $347.0 million across 5 years, with a median of $277.4 million in 2020.
- The largest YoY upside for EBT was 237.12% in 2017 against a maximum downside of 40.35% in 2017.
- Grifols' EBT stood at $206.1 million in 2016, then jumped by 237.12% to $694.7 million in 2017, then decreased by 3.93% to $667.4 million in 2018, then declined by 7.46% to $617.6 million in 2019, then plunged by 55.09% to $277.4 million in 2020.
- The last three EBT figures came in at $277.4 million (Q1 2020), $617.6 million (Q4 2019), and $162.4 million (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 2.89 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 8.85 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 5.99 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.04 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -3.50 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 2.08 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 2.58 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 3.17 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 3.24 Bn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 277.39 Mn |
| Dec 31, 2019 | 617.65 Mn |
| Mar 31, 2019 | 162.37 Mn |
| Dec 31, 2018 | 667.42 Mn |
| Jun 30, 2018 | 312.31 Mn |
| Mar 31, 2018 | 219.83 Mn |
| Dec 31, 2017 | 694.73 Mn |
| Jun 30, 2017 | 313.51 Mn |
| Mar 31, 2017 | 195.18 Mn |
| Dec 31, 2016 | 206.08 Mn |
| Sep 30, 2016 | 267.29 Mn |
| Jun 30, 2016 | 249.95 Mn |
| Mar 31, 2016 | 327.20 Mn |
| Dec 31, 2015 | 190.14 Mn |
| Sep 30, 2015 | 275.09 Mn |
| Jun 30, 2015 | 258.96 Mn |
| Mar 31, 2015 | 182.81 Mn |
| Sep 30, 2013 | 166.11 Mn |
| Jun 30, 2013 | 176.26 Mn |
| Mar 31, 2013 | 165.42 Mn |